Skip to content

Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease

Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01654471
Enrollment
47
Registered
2012-07-31
Start date
2012-08-31
Completion date
2014-09-30
Last updated
2014-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Occlusive Disease

Keywords

Walking Impairment Questionnaire, Peripheral arterial occlusive disease, Korean version

Brief summary

The aim of the study is to validate the Korean version of Walking Impairment Questionnaire in patients with peripheral arterial occlusive disease.

Detailed description

First, the original version of WIQ will be translated into Korean, then it will be translated into English, again. The translated version will be sent to the original author to compare with the original version. After correcting, the Korean version will be completed. The patients with peripheral arterial disease will fill in the Korean version of WIQ before starting treatments. Baseline results of arterial function test, toe-brachial index and treadmill test will be recorded. Three months later, the patients will complete the questionnaire again. Arterial function test, toe-brachial index and treadmill test also will be taken again after treatment and the correlation of WIQ and other exams will be evaluated.

Interventions

None listed

Sponsors

Astellas Pharma Korea, Inc.
CollaboratorINDUSTRY
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 19\ 80 years * claudication * Ankle brachial index \< 0.9 or TBI \< 0.7 (in patients with DM and ABI higher than 1.3) * patients who can complete the treadmill test (slope 12%, 2.4km/hr)

Exclusion criteria

* critical limb ischemia * Ankle pressure \< 40mmHg * claudication due to other causes (i.e. spinal stenosis, arthritis, etc) * patients with high risk of coronary artery syndrome during treadmill test

Design outcomes

Primary

MeasureTime frameDescription
Reproducibility of Korean version Walking Impairment QuestionnaireOne monthTo test reliatbility of WIQ Korean ver., reproducibility of the test was assessed by test-retest procedure of the baseline and 1month afterwards (intraclass correlation coefficient)
Correlation of WIQ score improvement and change in ABI and treadmill test results3 monthsCorrelation between changes in WIQ score and changes in ABI or treadmill test results (before and after surgical / radiological or pharmacological intervention) were assessed by Pearson's correlation test

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026